Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- befree-2016 importedOn "2016-02-19" NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_assertion wasGeneratedBy ECO_0000203 NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_assertion wasDerivedFrom befree-2016 NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_assertion SIO_000772 22592606 NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_assertion evidence source_evidence_literature NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.
- NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_assertion description "[In CML-iPSCs, the phosphorylation of ERK1/2, AKT, and JNK, which are essential for the maintenance of both BCR-ABL (+) leukemia cells and iPSCs, were unchanged after imatinib treatment, whereas the phosphorylation of signal transducer and activator of transcription (STAT)5 and CRKL was significantly decreased.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982881.RAmBdnJ1x5kXMSBOn74v1UiUuq-6SOFNxOZxlN18C7EfM130_provenance.